Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Masahiro, NOMOTO"'
Publikováno v:
Nihon Kikai Gakkai ronbunshu, Vol 90, Iss 930, Pp 23-00279-23-00279 (2024)
Aerators are necessary for the conservation of water quality in dams, as they increase water circulation and oxygenate the water. To estimate aerator performance characteristics in the field, the optimal spatial range, resolution, and sampling time i
Externí odkaz:
https://doaj.org/article/11d58414643e4bf3af3e5ca0abb58d3c
Autor:
Masahiro Nomoto, Yoshio Tsuboi, Kenichi Kashihara, Shih-Wei Chiu, Tetsuya Maeda, Hidemoto Saiki, Hirohisa Watanabe, Yasushi Shimo, Nobutaka Hattori, Takuhiro Yamaguchi, J-FIRST Investigators
Publikováno v:
PLoS ONE, Vol 19, Iss 10, p e0309297 (2024)
BackgroundNon-motor symptoms (NMS) are important factors when selecting treatments for patients with advanced Parkinson's disease (PD). We sought to elucidate the prescribing practices for advanced PD patients with NMS in Japanese clinical practice.M
Externí odkaz:
https://doaj.org/article/598bf0460fc049d1bdcb32f037436d10
Autor:
Nobutaka Hattori, Yuki Kogo, Michinori Koebis, Takayuki Ishida, Ippei Suzuki, Yoshio Tsuboi, Masahiro Nomoto
Publikováno v:
Frontiers in Neurology, Vol 12 (2022)
Background and PurposeNeuropsychiatric symptoms in Parkinson's disease (PD) have been shown to significantly affect quality of life (QOL). We investigated the impact of safinamide on depression and apathy when administered as an adjunct to levodopa i
Externí odkaz:
https://doaj.org/article/aaea7af9935b4baabb0f41d5503798a4
Publikováno v:
Parkinson's Disease, Vol 2022 (2022)
Background. Safinamide is a selective, reversible monoamine oxidase-B inhibitor with a sodium channel inhibitory effect. Published clinical evidence supports safinamide as an effective therapy for Parkinson’s disease (PD) with wearing-off. However,
Externí odkaz:
https://doaj.org/article/22644f11633f4356888ab97fe0e6fa9b
Publikováno v:
Parkinson's Disease, Vol 2022 (2022)
Objective. This study aimed to gain an understanding of patient and physician satisfaction with overall treatment and routine consultations for Parkinson’s disease in clinical practice. Methods. This observational, cross-sectional, web-based survey
Externí odkaz:
https://doaj.org/article/c8a1624f52f94acf990e72f00609a427
Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease
Autor:
Masahiro Nomoto, Masahiro Nagai, Noriko Nishikawa, Rina Ando, Yoshifumi Kagamiishi, Koji Yano, Shigeto Saito, Atsushi Takeda
Publikováno v:
eNeurologicalSci, Vol 13, Iss , Pp 8-13 (2018)
We conducted a phase I study investigating the efficacy, safety, and tolerability of ONO-2160, a newly developed levodopa pro-drug, and carbidopa compared with levodopa and carbidopa to stabilize levodopa plasma concentration fluctuations in Japanese
Externí odkaz:
https://doaj.org/article/91eb2501e202496dace147da54a25d4f
Publikováno v:
Internal Medicine. 62:839-847
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70aa1900cfd63741a99faa040fc7680c
https://doi.org/10.2169/internalmedicine.8527-21
https://doi.org/10.2169/internalmedicine.8527-21
Autor:
Rina Ando, Mohammed Emamussalehin Choudhury, Yuki Yamanishi, Win Thiri Kyaw, Madoka Kubo, Mariko Kannou, Noriko Nishikawa, Junya Tanaka, Masahiro Nomoto, Masahiro Nagai
Publikováno v:
Journal of Pharmacological Sciences, Vol 136, Iss 4, Pp 266-271 (2018)
Treatment with dopaminergic agents result excessive daytime sleepiness (EDS) and some studies have shown the benefit of using modafinil for treating excessive daytime sleepiness of Parkinson's disease (PD) patient. We investigated whether modafinil h
Externí odkaz:
https://doaj.org/article/905c855158434995a0937f980edf8a77
Autor:
Yoshio Tsuboi, Shih-Wei Chiu, Nobutaka Hattori, Kenichi Kashihara, Hirohisa Watanabe, Masahiro Nomoto, Hidemoto Saiki, Tetsuya Maeda, Takuhiro Yamaguchi, Yasushi Shimo
Publikováno v:
Parkinsonism & Related Disorders. 91:115-120
Introduction The non-motor symptoms (NMSs) of Parkinson's disease (PD) significantly impact the patient's health-related quality of life. This subanalysis of the J-FIRST study evaluated the effect of istradefylline, a selective adenosine A2A receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed962ea55890829b3bed07c9f68bf610
http://hdl.handle.net/10295/00006146
http://hdl.handle.net/10295/00006146
Autor:
Hirotaka Iwaki, Masaru Kuriyama, Shuichiro Neshige, Shinichi Takeshima, Takahiro Himeno, Kazuhiro Takamatsu, Yutaka Shimoe, Hiromitsu Kobayashi, Masahiro Nomoto, Akio Tanaka
Publikováno v:
eNeurologicalSci, Vol 1, Iss 3, Pp 47-50 (2015)
We report 10 cases with arterial ischemic stroke (AIS) with nephrotic syndrome (NS), and clarified its incidence and clinical characteristics. The patients having albumin less than 3.0 g/dl and serum cholesterol greater than 250 mg/dl at the same tim
Externí odkaz:
https://doaj.org/article/532eaedcaf7f4b77a2d2d2f07626ce9f